REduced Frequency ImmuNE Checkpoint Inhibition in Cancers

Clinical trial NCT04913025 · UNKNOWN

Trial details

NCT number: NCT04913025
Sponsor: University College, London
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma Melanoma

Start date: 2022-05-26
Primary completion: 2025-04-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.